glucagon like peptide 1 glp 1 Glucagon-like peptide-1 (GLP-1), released from the intestine, informs Insights into a possible role

it offers several health benefits that can address various conditions: 1

Chronic conditions show gradual improvement

What can trigger MCAS flare-ups

R., Chamanara, M., Naghsh, N., & Mirzaei, H

Phytochemistry 116:6977 Cobbett CS, May MJ, Howden R, Rolls B (1998) The glutathione- deficient, cadmium-sensitive mutant, cad2-1, of Arabidopsis thaliana is deficient in gamma-glutamylcysteine synthetase

The guidelines warn, however, that GLP-1 receptor agonist therapy is not indicated for all patients and should be used with caution in patients with a history of significant gastrointestinal disease, such as a diagnosis of gastroparesis, due to a possible exacerbation of the condition with incretin mimetic therapy